Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like 5 Drugmakers That are Soaring Insanely High Right Now January 28, 2018 SurModics Announces 2017 Annual Shareholders Meeting February 8, 2017 Pharma Bro Shkreli's Ex-Lawyer Convicted of Helping Him Defraud Pharma Firm December 27, 2017
